229 related articles for article (PubMed ID: 30769)
1. Lorazepam in anxiety associated with chronic enteritis and ulcerative colitis.
Stokes DK
J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):53-7. PubMed ID: 30769
[TBL] [Abstract][Full Text] [Related]
2. The effect of lorazepam on hypertension-associated anxiety: a double-blind study.
Hart WL; Parmley LF
J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):41-5. PubMed ID: 30767
[TBL] [Abstract][Full Text] [Related]
3. A clinical assessment of lorazepam in the treatment of anxiety associated with gastrointestinal symptomatology.
Berkowitz JM
J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):46-52. PubMed ID: 30768
[TBL] [Abstract][Full Text] [Related]
4. Clinical assessment of the safety and efficacy of lorazepam, a new benzodiazepine derivative, in the treatment of anxiety.
Pinosky DG
J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):24-9. PubMed ID: 30763
[TBL] [Abstract][Full Text] [Related]
5. Antianxiety effects of lorazepam in patients with cardiovascular symptomatology.
Finkel S
J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):35-40. PubMed ID: 30766
[TBL] [Abstract][Full Text] [Related]
6. Studies with oral lorazepam in anxiety neurosis associated with depressive symptomatology.
McCurdy L; Schatzberg AF
J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):30-4. PubMed ID: 30765
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
[TBL] [Abstract][Full Text] [Related]
8. Clinical assessment of lorazepam in anxiety: a double-blind study.
Olgiati SG
Curr Ther Res Clin Exp; 1975 Jan; 17(1):13-22. PubMed ID: 237741
[No Abstract] [Full Text] [Related]
9. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice.
Nguyen N; Fakra E; Pradel V; Jouve E; Alquier C; Le Guern ME; Micallef J; Blin O
Hum Psychopharmacol; 2006 Apr; 21(3):139-49. PubMed ID: 16625522
[TBL] [Abstract][Full Text] [Related]
10. Lorazepam in the management of anxiety associated with chronic gastrointestinal disease: a double-blind study.
Kasich AM
Curr Ther Res Clin Exp; 1976 Mar; 19(3):292-306. PubMed ID: 5247
[No Abstract] [Full Text] [Related]
11. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
Cutler NR; Sramek JJ; Wardle TS; Hesselink JM; Roeschen JK
Psychopharmacol Bull; 1993; 29(2):303-8. PubMed ID: 7904761
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of alpidem, a nonbenzodiazepine, and lorazepam in patients with nonpsychotic anxiety.
Diamond BI; Nguyen H; O'Neal E; Ochs R; Kaffeman M; Borison RL
Psychopharmacol Bull; 1991; 27(1):67-71. PubMed ID: 1677774
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of bedtime dosing of benzodiazepines: a placebo-controlled comparison of halazepam and clorazepate.
Aden GC; O'Hair DE
Clin Ther; 1980; 3(3):209-18. PubMed ID: 6109568
[TBL] [Abstract][Full Text] [Related]
14. A comparison of prazepam, diazepam, lorazepam and placebo in anxious outpatients in non-psychiatric private practices.
Zung WW; Daniel JT; King RE; Moore DT
J Clin Psychiatry; 1981 Jul; 42(7):280-4. PubMed ID: 6113234
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
Lemoine P; Touchon J; Billardon M
Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam].
Danion JM; Brion S; Escande M; Ropert R; Sacquepee L; Singer L; Scotto JC
Encephale; 1984; 10(3):135-8. PubMed ID: 6389091
[TBL] [Abstract][Full Text] [Related]
17. Double-blind placebo cross-over study of long-acting (chlordesmethyldiazepam) versus short-acting (lorazepam) benzodiazepines in generalized anxiety disorders.
Bertin I; Colombo G; Furlanut M; Benetello P
Int J Clin Pharmacol Res; 1989; 9(3):203-8. PubMed ID: 2568350
[TBL] [Abstract][Full Text] [Related]
18. Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
Busto UE; Naranjo CA; Bremner KE; Peachey JE; Bologa M
J Psychiatry Neurosci; 1998 Jan; 23(1):35-44. PubMed ID: 9505058
[TBL] [Abstract][Full Text] [Related]
19. Time-blind videotaped evaluation of injectable diazepam, lorazepam and placebo.
Bobon DP; Fanielle J; Mormont C; Breulet M; Bobon J
Acta Psychiatr Belg; 1978; 78(4):619-34. PubMed ID: 31063
[TBL] [Abstract][Full Text] [Related]
20. A multiclinic double-blind trial of the anxiolytic properties of lorazepam in psychiatric outpatient practice [proceedings].
Lipman R; Vanov SK; Richards DJ
Psychopharmacol Bull; 1977 Apr; 13(2):17-9. PubMed ID: 16308
[No Abstract] [Full Text] [Related]
[Next] [New Search]
